BeOne Medicines (ONC) EBT Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 47.45% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 12.01% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1.05% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 20.92% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 40.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.43% |
| Dec 31, 2025 | 32.88% |
| Sep 30, 2025 | 31.37% |
| Jun 30, 2025 | 29.63% |
| Mar 31, 2025 | 27.03% |
| Dec 31, 2024 | 47.97% |
| Sep 30, 2024 | 39.00% |
| Jun 30, 2024 | 39.59% |
| Mar 31, 2024 | -81.05% |
| Dec 31, 2023 | 10.05% |
| Sep 30, 2023 | 36.21% |
| Jun 30, 2023 | -2.85% |
| Mar 31, 2023 | 2.49% |
| Dec 31, 2022 | -4.25% |
| Sep 30, 2022 | -20.91% |
| Jun 30, 2022 | -88.07% |
| Mar 31, 2022 | -35.98% |
| Dec 31, 2021 | -30.09% |
| Sep 30, 2021 | -44.02% |
| Jun 30, 2021 | -43.96% |
| Mar 31, 2021 | 36.98% |
| Dec 31, 2020 | -72.22% |
| Sep 30, 2020 | -79.76% |
| Jun 30, 2020 | -77.43% |
| Mar 31, 2020 | -93.13% |
| Dec 31, 2019 | -115.79% |
| Sep 30, 2019 | -106.60% |
| Jun 30, 2019 | -51.75% |
| Mar 31, 2019 | -96.87% |
| Dec 31, 2018 | -136.27% |
| Sep 30, 2018 | -117.97% |
| Jun 30, 2018 | -205.65% |
| Mar 31, 2018 | -119.86% |